A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
作者信息
Hakim Z, Pierson J F, Pathak D S
机构信息
Roche Bioscience, Palo Alto, CA, USA.
出版信息
Pharm Pract Manag Q. 1996 Apr;16(1):79-97.
PMID:10157744
Abstract
摘要
相似文献
1
A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.一种进行机构特定成本效益分析的提议模型：以降脂药物为例的案例研究。
Pharm Pract Manag Q. 1996 Apr;16(1):79-97.
2
Theory and methods of economic evaluation of health care.医疗保健经济评估的理论与方法。
Dev Health Econ Public Policy. 1996;4:1-245.
3
Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
Hosp Formul. 1993 Apr;28(4):365-6, 371-3, 377-8.
4
Proposed drug-drug cost effectiveness methodology.拟议的药物-药物成本效益方法。
Drug Intell Clin Pharm. 1987 Feb;21(2):211-6.
5
Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
Hosp Pharm. 1986 Nov;21(11):1072-5.
6
Where does high-quality research in economic evaluation come from?经济评估方面的高质量研究源自何处？
Pharmacotherapy. 2009 Jan;29(1):1-2. doi: 10.1592/phco.29.1.1.
7
Evaluation and justification of clinical pharmacy services.临床药学服务的评估和论证。
Expert Rev Pharmacoecon Outcomes Res. 2009 Dec;9(6):539-45. doi: 10.1586/erp.09.57.
8
Pharmacoeconomic principles and methods: including pharmacoeconomics into hospital pharmacy practice.
Hosp Pharm. 1994 Nov;29(11):1035-6, 1039-40.
9
Pharmacoeconomic factors in the treatment of acute hypertension.
Hosp Formul. 1994 Aug;29 Suppl 2:S15-20.
10
Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.医疗保健评估中的陈述偏好方法：卫生经济学中一种新兴的方法论范式。
Appl Health Econ Health Policy. 2003;2(4):213-24.
Zotero 插件